As of 2026-03-27, the EV/EBITDA ratio of Allscripts Healthcare Solutions Inc (MDRX) is 3.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MDRX's latest enterprise value is 259.72 mil USD. MDRX's TTM EBITDA according to its financial statements is 75.27 mil USD. Dividing these 2 quantities gives us the above MDRX EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 8.1x | 6.6x |
| Forward P/E multiples | 7.5x - 9.1x | 8.4x |
| Fair Price | 4.55 - 7.85 | 5.85 |
| Upside | -2.1% - 68.9% | 25.8% |
| Date | EV/EBITDA |
| 2026-03-25 | 3.45 |
| 2026-03-23 | 3.38 |
| 2026-03-20 | 3.23 |
| 2026-03-19 | 3.31 |
| 2026-03-18 | 3.45 |
| 2026-03-17 | 3.31 |
| 2026-03-16 | 3.31 |
| 2026-03-13 | 3.72 |
| 2026-03-11 | 3.23 |
| 2026-03-10 | 3.02 |
| 2026-03-09 | 3.45 |
| 2026-03-06 | 2.89 |
| 2026-03-05 | 3.09 |
| 2026-03-04 | 2.89 |
| 2026-03-03 | 3.31 |
| 2026-03-02 | 3.23 |
| 2026-02-27 | 3.81 |
| 2026-02-26 | 3.23 |
| 2026-02-25 | 3.23 |
| 2026-02-23 | 2.94 |
| 2026-02-20 | 2.96 |
| 2026-02-19 | 3.23 |
| 2026-02-18 | 3.23 |
| 2026-02-17 | 2.94 |
| 2026-02-13 | 2.94 |
| 2026-02-12 | 3.23 |
| 2026-02-11 | 3.25 |
| 2026-02-10 | 3.25 |
| 2026-02-09 | 3.32 |
| 2026-02-05 | 3.58 |
| 2026-02-04 | 3.38 |
| 2026-02-03 | 3.45 |
| 2026-02-02 | 3.67 |
| 2026-01-30 | 3.61 |
| 2026-01-29 | 3.23 |
| 2026-01-27 | 3.83 |
| 2026-01-26 | 3.81 |
| 2026-01-23 | 3.81 |
| 2026-01-22 | 3.85 |
| 2026-01-21 | 3.38 |
| 2026-01-20 | 3.85 |
| 2026-01-16 | 3.38 |
| 2026-01-15 | 3.80 |
| 2026-01-14 | 3.59 |
| 2026-01-13 | 3.63 |
| 2026-01-12 | 3.59 |
| 2026-01-09 | 3.45 |
| 2026-01-08 | 3.74 |
| 2026-01-06 | 3.74 |
| 2026-01-05 | 3.38 |